These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 12297708)

  • 1. Increased coronary vascular resistance cannot be reduced by inhibiting sympathetic overactivity in hypertension.
    Sundell J; Laine H; Luotolahti M; Nuutila P; Knuuti J
    J Vasc Res; 2002; 39(5):456-62. PubMed ID: 12297708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blunted coronary vasoreactivity to insulin is an early alteration in hypertension.
    Sundell J; Laine H; Luotolahti M; Nuutila P; Kalliokoski K; Raitakari O; Knuuti J
    J Vasc Res; 2003; 40(1):58-67. PubMed ID: 12644726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men.
    Laine H; Nuutila P; Luotolahti M; Meyer C; Elomaa T; Koskinen P; Rönnemaa T; Knuuti J
    J Clin Endocrinol Metab; 2000 May; 85(5):1868-73. PubMed ID: 10843167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term changes in inflammatory response protein (hsCRP) do not parallel with changes in coronary vasoreactivity in obese men.
    Sundell J; Laine H; Nuutila P; Luotolahti M; Knuuti J
    Int J Obes (Lond); 2006 Mar; 30(3):460-7. PubMed ID: 16261183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reflex control of coronary vascular tone by cardiopulmonary receptors in humans.
    Trimarco B; Vigorito C; Cuocolo A; Ricciardelli B; De Luca N; Volpe M; Lembo G; Condorelli M
    J Am Coll Cardiol; 1988 May; 11(5):944-52. PubMed ID: 3356840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological, hemodynamic and biochemical mechanisms involved in the blood pressure lowering effects of pergolide, in normotensive and hypertensive dogs.
    Cavero I; Lorrain J; Di Paola ED; Lhoste F; Payen B; Dennis T; Scatton B
    J Pharmacol Exp Ther; 1985 Dec; 235(3):798-809. PubMed ID: 2934543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodynamics, plasma noradrenaline and plasma renin in hypertensive and normotensive teenagers.
    Hofman A; Roelandt JT; Boomsma F; Schalekamp MA; Valkenburg HA
    Clin Sci (Lond); 1981 Aug; 61(2):169-74. PubMed ID: 7021039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal hemodynamics and the renin-angiotensin-aldosterone system in normotensive subjects with hypertensive and normotensive parents.
    van Hooft IM; Grobbee DE; Derkx FH; de Leeuw PW; Schalekamp MA; Hofman A
    N Engl J Med; 1991 May; 324(19):1305-11. PubMed ID: 2017226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agreement among three different indices of sympathetic nervous system activity in essential hypertension.
    Esler M; Zweifler A; Randall O; Julius S; DeQuattro V
    Mayo Clin Proc; 1977 Jun; 52(6):379-82. PubMed ID: 865134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of naloxone on muscle sympathetic nerve activity, systemic and calf haemodynamics and ambulatory blood pressure after exercise in mild essential hypertension.
    Hara K; Floras JS
    J Hypertens; 1995 Apr; 13(4):447-61. PubMed ID: 7629406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle sympathetic activity and plasma noradrenaline in normotensive and hypertensive man.
    Mörlin C; Wallin BG; Eriksson BM
    Acta Physiol Scand; 1983; 119(2):117-21. PubMed ID: 6659984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment.
    Endemann DH; Pu Q; De Ciuceis C; Savoia C; Virdis A; Neves MF; Touyz RM; Schiffrin EL
    Hypertension; 2004 Feb; 43(2):399-404. PubMed ID: 14707158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular responsiveness to norepinephrine in mild essential hypertension.
    Lenders JW; De Boo T; Lemmens WA; Willemsen JJ; Thien T
    Am J Cardiol; 1989 May; 63(17):1231-4. PubMed ID: 2711993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and Angiotensin neuromodulation.
    Schlaich MP; Lambert E; Kaye DM; Krozowski Z; Campbell DJ; Lambert G; Hastings J; Aggarwal A; Esler MD
    Hypertension; 2004 Feb; 43(2):169-75. PubMed ID: 14610101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma interleukin-6 and tumor necrosis factor-alpha can predict coronary endothelial dysfunction in hypertensive patients.
    Naya M; Tsukamoto T; Morita K; Katoh C; Furumoto T; Fujii S; Tamaki N; Tsutsui H
    Hypertens Res; 2007 Jun; 30(6):541-8. PubMed ID: 17664858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma noradrenaline concentrations and haemodynamics in the early stage of essential hypertension.
    Miura Y; Kobayashi K; Sakuma H; Tomioka H; Adachi M; Yoshinaga K
    Clin Sci Mol Med Suppl; 1978 Dec; 4():69s-71s. PubMed ID: 282101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum leptin is associated with attenuated coronary vasoreactivity.
    Sundell J; Huupponen R; Raitakari OT; Nuutila P; Knuuti J
    Obes Res; 2003 Jun; 11(6):776-82. PubMed ID: 12805399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of cardiovascular hypersensitivity to norepinephrine by potassium supplementation in normotensive members of hypertensive families and patients with essential hypertension.
    Bianchetti MG; Beretta-Piccoli C; Weidmann P; Ferrier C; Link L; Gerber A
    J Hypertens Suppl; 1984 Dec; 2(3):S445-8. PubMed ID: 6599696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: a LIFE substudy.
    Olsen MH; Wachtell K; Meyer C; Hove JD; Palmieri V; Dige-Petersen H; Rokkedal J; Hesse B; Ibsen H
    J Hum Hypertens; 2004 Jun; 18(6):445-52. PubMed ID: 15014539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
    Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
    Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.